The House Energy and Commerce Health Subcommittee today concluded a two-day hearing on more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies, which follows a similar hearing last month on 25 other bills. Witnesses at the latest hearing included Michael Botticelli, executive director of the Grayken Center for Addiction at Boston Medical Center, and John Kravitz, chief information officer for Danville, PA-based Geisinger Health System. Botticelli, a former director of the White House Office of National Drug Control Policy and Massachusetts Bureau of Substance Addiction Services, emphasized the “critical role” that Medicaid plays in addressing the opioid epidemic. Kravitz described how the integrated health system has used electronic prescribing and information technology strategies to reduce opioid prescriptions, drug diversion and the cost of care. The Senate Health, Education, Labor and Pensions Committee yesterday held a hearing on a discussion draft of bipartisan legislation to address the opioid crisis, which the committee will mark up on April 24. 

Related News Articles

Headline
The House Jan. 22 voted 341-88 to pass a three-bill minibus for fiscal year 2026 that includes funding for key health programs and other bipartisan health…
Headline
The AHA Jan. 20 made recommendations to Congress on modernizing the Medicare Access and CHIP Reauthorization Act. Among the proposals, the AHA recommended…
Headline
The comment period for the Centers for Medicare & Medicaid Services' proposed rule for policies governing the Medicare Advantage and Part D programs for…
Headline
The Medicare Payment Advisory Commission Jan. 15 voted to recommend that Congress update Medicare payment rates for hospital inpatient and outpatient services…
Headline
UnitedHealth Group announced Jan. 14 that it launched a six-month pilot program to reduce Medicare Advantage payment processing times by half for rural…
Headline
A Senate Judiciary Committee report released Jan. 12 found that UnitedHealth Group used “aggressive strategies” to maximize its Medicare Advantage risk-…